Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01819519 · ClinicalTrials.gov registry record · NA

Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus

A NA study, sponsored by Women and Infants Hospital of Rhode Island.

Completed
Registry status
NA
Development phase
223
Enrollment target

NCT01819519 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 223 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01819519, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.

COMPLETED
Registry status
NA
Development phase
223 participants
Enrollment target

Study Summary

The purpose of this study is to develop a brief screening and behavioral intervention for the prevention of congenital cytomegalovirus (CMV) that will both be acceptable to clinic staff and feasible to implement as part of routine clinical prenatal care, and to test whether behavioral intervention for susceptible pregnant women can lead to a behavioral change that is likely to lead to decreased primary CMV infection. The study research assistants will enroll pregnant women who are less than 20 weeks' gestation, either English or Spanish-speaking and that do not have a primary CMV infection (never been infected or previously infected). Enrollment will occur during the woman's prenatal visit.

Interventions

  • BEHAVIORAL Educational Intervention

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2013-03
Est. Completion 2015-03
Phase NA

What the Registry Record Tells You About NCT01819519

The ClinicalTrials.gov registry entry for NCT01819519 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Educational Intervention is the first listed.

NCT01819519 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01819519 about?

NCT01819519 is a clinical study titled "Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus". The purpose of this study is to develop a brief screening and behavioral intervention for the prevention of congenital cytomegalovirus (CMV) that will both be acceptable to clinic staff and feasible to implement as part of routine clinical prenatal care, and to test whether behavioral intervention f...

What is the current status of trial NCT01819519?

This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2013-03. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01819519?

The interventions under investigation include: Educational Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01819519?

This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.